TRANSPHORM MERGER ALERT: Shareholders Concerned About Sale to Renesas Should Contact Julie & Holleman LLP About Ongoing Investigation
Provided By PR Newswire
Last update: Jan 24, 2024
NEW YORK, Jan. 24, 2024 /PRNewswire/ -- Julie & Holleman LLP, a nationally recognized shareholder rights firm, is investigating the proposed $5.10 per share acquisition of Transphorm, Inc. (Nasdaq: TGAN) to Renesas Electronics Corporation. Julie & Holleman believes the deal price may be unfair and has identified potential conflicts of interest.
Read more at prnewswire.com
